Regardless of the sequential decrease in Current Liabilities, during the fourth quarter 2025, Quick Ratio deteriorated to 3.01 below Brainsway Ltd 's average Quick Ratio.

Within Medical Equipment & Supplies industry 58 other companies have achieved higher Quick Ratio than Brainsway Ltd in fourth quarter 2025. While Quick Ratio total ranking in the fourth quarter 2025 has deteriorated compared to the prior quarter from 656 to 1065.

Explain Quick Ratio?
How much Cash & cash equivalents BWAY�s has?
What are BWAY�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

BWAY Quick Ratio	(Dec 31 2025) Q4	0 Q3	0 Q2	0 Q1	(Dec 31 2024) Q4
Y / Y Current Liabilities Change	5.74 %	46.59 %	87.91 %	46.59 %	41.63 %
Y / Y Cash & cash equivalent Change	-2.37 %	-2.37 %	41.89 %	-2.37 %	50.8 %
Quick Ratio MRQ	3.01	3.01	2.36	3.01	3.26
BWAY's Total Ranking	# 1065	# 656	#	#	#
Seq. Current Liabilities Change	0 %	-21.99 %	28.19 %	5.74 %	38.62 %
Seq. Cash & cash equivalent Change	0 %	-0.31 %	0.31 %	-2.37 %	0 %

Quick Ratio fourth quarter 2025 Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 59
Healthcare Sector	# 431
Overall Market	# 1065

Quick Ratio Statistics
High	Average	Low
6.41	3.53	1.08
(Sep 30 2019)		(Dec 31 2023)

Financial Statements
Brainsway Ltd 's Current Liabilities	$ 22 Millions	Visit BWAY's Balance sheet
Brainsway Ltd 's Cash & cash equivalent	$ 68 Millions	Visit BWAY's Balance sheet
Source of BWAY's Sales		Visit BWAY's Sales by Geography

Cumulative Brainsway Ltd 's Quick Ratio

BWAY's Quick Ratio for the trailling 12 Months

BWAY Quick Ratio	(Dec 31 2025) 12 Months	0 12 Months	0 12 Months	0 12 Months	(Dec 31 2024) 12 Months
Y / Y Current Liabilities TTM Growth	43.1 %	55.75 %	58.55 %	49.25 %	51.93 %
Y / Y Cash & cash equivalent TTM Growth	5.91 %	17.25 %	57.9 %	86.44 %	230 %
Quick Ratio TTM	2.81	2.87	3.12	3.41	3.8
Total Ranking TTM	# 3602	# 3678	#	#	#
Seq. Current Liabilities TTM Growth	1.28 %	8.13 %	18.12 %	10.62 %	10.24 %
Seq. Cash & cash equivalent TTM Growth	-0.6 %	-0.6 %	7.89 %	-0.64 %	10.05 %

Quick ratio ranking by company, industry and sector >> Back to BWAY Financial Strength Comparisons >> Go to Compare BWAY Quick Ratio to its Competitors

News about Brainsway Ltd Quick Ratio

BrainsWay Announces US$20 Million Private Placement with Valor Equity Partners

BrainsWayns Strategic Expansion and Financial Maneuvering: A New Chapter in Mental Health CareIn a rapidly changing landscape where mental health issues dominate societal concerns, BrainsWay Ltd. is poised to solidify its position as a leader in innovative treatments. The company, recognized for its cutting-edge transcranial magnetic stimulation (TMS) technologies, has recently announced a significant expansion venture on the U.S. East Coast. This expansion, coupled with a crucial funding milestone, highlights BrainsWayns commitment to evolving mental health care while navigating its financial metrics.Key Developments and Financial Overview1. Expansion into the U.S. East Coast: BrainsWay has made a notable commitment to increase its footprint across the U.S. East Coast by securing an order for 14 of its advanced Deep TMS devices from a prominent mental health network. This strategic move is emblematic of the growing recognition of TMS as an effective therapeutic option, particularly for patients struggling with depression and other related disorders.

On the trailing twelve months basis Due to unchanged in Current Liabilities in the Q4 2025 to $22.50 millions, cumulative Quick Ratio decreased to 2.81 below the average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 180 other companies have achieved higher Quick Ratio than Brainsway Ltd . While Quick Ratio overall ranking has improved so far to 3602, from total ranking during the twelve months ending third quarter 2025 at 3678.

Explain Quick Ratio?
How much Cash & cash equivalents BWAY�s has?
What are BWAY�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Medical Equipment & Supplies Industry	# 181
Healthcare Sector	# 873
Within the Market	# 3602

trailing twelve months Quick Ratio Statistics
High	Average	Low
5.84	3.28	1.08
(Dec 31 2022)		(Dec 31 2023)

Companies with similar Quick Ratio in the quarter ending Dec 31 2025, within Medical Equipment & Supplies Industry	Quick Ratio	Dec 31 2025 MRQ Cash & cash equivalent	Dec 31 2025 MRQ Current Liabilities
Carlsmed Inc	7.69	$ 109.793 Millions	$ 14.280 Millions
EBR Systems, Inc.	7.57	$ 101.595 Millions	$ 13.422 Millions
Inmode Ltd	7.16	$ 555.244 Millions	$ 77.569 Millions
Beta Bionics Inc	7.09	$ 219.125 Millions	$ 30.924 Millions
Orchestra Biomed Holdings Inc	6.66	$ 106.512 Millions	$ 15.985 Millions
Innovative Eyewear Inc	6.23	$ 6.511 Millions	$ 1.045 Millions
Nutriband Inc	5.83	$ 4.575 Millions	$ 0.784 Millions
Cvrx inc	5.69	$ 75.708 Millions	$ 13.317 Millions
Transmedics Group Inc	5.47	$ 488.366 Millions	$ 89.305 Millions
Autonomix Medical Inc	5.35	$ 9.136 Millions	$ 1.707 Millions
Inspiremd Inc	5.06	$ 54.211 Millions	$ 10.712 Millions
Perspective Therapeutics Inc	5.05	$ 144.737 Millions	$ 28.679 Millions
Iradimed Corporation	5.03	$ 51.159 Millions	$ 10.180 Millions
Collplant Biotechnologies Ltd	5.00	$ 5.950 Millions	$ 1.191 Millions
Soleno Therapeutics Inc	4.98	$ 305.472 Millions	$ 61.363 Millions
Heartflow Inc	4.85	$ 176.786 Millions	$ 36.448 Millions
Sensus Healthcare Inc	4.68	$ 22.083 Millions	$ 4.722 Millions
Orasure Technologies Inc	4.64	$ 199.278 Millions	$ 42.947 Millions
Outset Medical Inc	4.49	$ 168.946 Millions	$ 37.630 Millions
Irhythm Holdings Inc	4.46	$ 583.763 Millions	$ 131.003 Millions
Omada Health Inc	4.38	$ 222.036 Millions	$ 50.668 Millions
Procept Biorobotics Corporation	4.35	$ 286.503 Millions	$ 65.795 Millions
Clearpoint Neuro Inc	4.27	$ 45.923 Millions	$ 10.765 Millions
Nexalin Technology Inc	4.20	$ 3.723 Millions	$ 0.887 Millions
Alpha Pro Tech Ltd	4.19	$ 16.988 Millions	$ 4.058 Millions
Vicarious Surgical Inc	3.96	$ 9.792 Millions	$ 2.475 Millions
Icecure Medical Ltd	3.90	$ 8.897 Millions	$ 2.280 Millions
Regentis Biomaterials Ltd	3.89	$ 7.378 Millions	$ 1.895 Millions
Biolife Solutions Inc	3.87	$ 88.927 Millions	$ 22.979 Millions
Solana Company	3.85	$ 7.282 Millions	$ 1.890 Millions

Date modified: 2026-04-24T15:35:29+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.